Bluejay Diagnostics (BJDX) Share-based Compensation (2020 - 2025)
Bluejay Diagnostics' (BJDX) quarterly Share-based Compensation came in at $74.0 in Q4 2025, up 102.87% year-on-year from $36.48 in Q4 2024, and down 59.56% quarter-over-quarter from $183.0 in Q3 2025.
Bluejay Diagnostics (BJDX) Share-based Compensation (2020 - 2025) Analysis & Trends
Bluejay Diagnostics has disclosed Share-based Compensation across 6 years of filings, most recently posting $74.0 for Q4 2025.
- Share-based Compensation for Q4 2025 came in at $74.0, up 102.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.0 (down 99.97% YoY), and the FY2025 annual result was $6.0, down 99.97% from the prior year.
- Share-based Compensation came in at $74.0 for Q4 2025 at Bluejay Diagnostics, down from $183.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $219589.0 in Q1 2023 to a low of -$42482.0 in Q3 2023.
- The 5-year median for Share-based Compensation is $5401.0 (2024), against an average of $35540.4.
- Across the five-year window, Share-based Compensation soared 76781.71% in 2022 and slumped 137.52% in 2023, its largest moves.
- Bluejay Diagnostics' Share-based Compensation stood at $21635.0 in 2021, then soared by 304.83% to $87586.0 in 2022, then slumped by 117.77% to -$15565.0 in 2023, then soared by 83.41% to -$2582.0 in 2024, then surged by 102.87% to $74.0 in 2025.
- The last three Share-based Compensation figures came in at $74.0 (Q4 2025), $183.0 (Q3 2025), and -$1563.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.00 |
| Dec 31, 2025 | 74.00 |
| Sep 30, 2025 | 183.00 |
| Sep 30, 2025 | 183.00 |
| Jun 30, 2025 | -1,563.00 |
| Jun 30, 2025 | -1,563.00 |
| Mar 31, 2025 | 1,312.00 |
| Mar 31, 2025 | 1,312.00 |
| Dec 31, 2024 | -2,582.00 |
| Dec 31, 2024 | -2,582.00 |
| Sep 30, 2024 | 4,792.00 |
| Sep 30, 2024 | 4,792.00 |
| Jun 30, 2024 | 6,010.00 |
| Jun 30, 2024 | 6,010.00 |
| Mar 31, 2024 | 11,874.00 |
| Mar 31, 2024 | 11,874.00 |
| Dec 31, 2023 | -15,565.00 |
| Dec 31, 2023 | -15,565.00 |
| Sep 30, 2023 | -42,482.00 |
| Sep 30, 2023 | -42,482.00 |